Inhibition of sPLA 2 enzyme activity by cell-permeable antioxidant EUK-8 and downregulation of p38, Akt, and p65 signals induced by sPLA 2 in inflammatory mouse paw edema model.

Autor: Jayachandra K; Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India., Gowda MDM; Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India., Rudresha GV; Evolutionary Venomics Lab, Centre for Ecological Sciences, Indian Institute of Science, Bengaluru, Karnataka, India., Manjuprasanna VN; Department of Hematology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Urs AP; Comprehensive Cancer Centre, The Ohio State University, Columbus, Ohio, USA., Nandana MB; Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India., Bharatha M; Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India., Jameel NM; Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India., Vishwanath BS; Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India.
Jazyk: angličtina
Zdroj: Journal of cellular biochemistry [J Cell Biochem] 2023 Feb; Vol. 124 (2), pp. 294-307. Date of Electronic Publication: 2022 Dec 31.
DOI: 10.1002/jcb.30366
Abstrakt: The arachidonic acid (AA) metabolic pathway, plays a vital role in the production of eicosanoids by the action of pro-inflammatory secretory phospholipase A 2 (PLA 2 ). Release of eicosanoids is known to be involved in many inflammatory diseases. Identification of the inhibitory molecules of this AA pathway enzyme along with the regulation of intracellular signaling cascades may be a finer choice to develop as a powerful anti-inflammatory drug. In this regard, we have screened few cell-permeable antioxidant molecules Tempo, Mito-TEMPO, N,N'-Bis(salicylideneamino)ethane-manganese(II) (EUK)-134, and EUK-8 against pro-inflammatory sPLA 2 s. Among these, we found EUK-8 is a potent inhibitor with its IC 50 value ranges 0.7-2.0 µM for sPLA 2 s isolated from different sources. Furthermore, docking studies confirm the strong binding of EUK-8 towards sPLA 2 . In vivo effect of EUK-8 was studied in HSF-sPLA 2 -induced edema in mouse paw model. In addition to neutralizing the edema, EUK-8 significantly reduces the phosphorylation level of inflammatory proteins such as p38 member of MAPK pathway, Akt, and p65 along with the suppression of pro-inflammatory cytokine (interleukin-6) and chemokine (CXCL1) in edematous tissue. This shows that EUK-8 not only inhibits the sPLA 2 activity, it also plays an important role in the regulation of sPLA 2 -induced cell signaling cascades. Apart from the sPLA 2 inhibition, we also examine the regulatory actions of EUK-8 with other downstream enzymes of AA pathway such as 5-LOX assay in human polymorphonuclear leukocytes (PMNs) and COX-2 expression in carrageenan-λ induced paw edema. Here EUK-8 significantly inhibits 5-LOX enzyme activity and downregulates COX-2 expression. These data indicate that EUK-8 found to be a promising multitargeted inhibitory molecule toward inflammatory pathway. In conclusion, mitochondrial targeted antioxidant EUK-8 is not only the powerful antioxidant, also a potent anti-inflammatory molecule and may be a choice of molecule for pharmacological applications.
(© 2022 Wiley Periodicals LLC.)
Databáze: MEDLINE